Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Transplantation|February 26, 2019
Analysis of 75 Candidate SNPs Associated With Acute Rejection in Kidney Transplant Recipients: Validation of rs2910164 in MicroRNA MIR146AWilliam S Oetting, David P Schladt, Casey R Dorr, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 24, 2017
CRISPR/Cas9 Genetic Modification of CYP3A5 *3 in HuH-7 Human Hepatocyte Cell Line Leads to Cell Lines with Increased Midazolam and Tacrolimus MetabolismCasey R Dorr, Rory P Remmel, Amutha Muthusamy, et al.Transplantation|February 16, 2024
Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in TransplantationMoataz E Mohamed, Abdelrahman Saqr, Christopher Staley, et al.Journal of Clinical Pharmacology|January 29, 2021
Precision Dosing for Tacrolimus Using Genotypes and Clinical Factors in Kidney Transplant Recipients of European AncestryMahmoud Al-Kofahi, William S Oetting, David P Schladt, et al.Blood|November 24, 2001
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group studyA F List, K J Kopecky, C L Willman, et al.The Pharmacogenomics Journal|November 17, 2018
Identification of genetic variants associated with tacrolimus metabolism in kidney transplant recipients by extreme phenotype sampling and next generation sequencingCasey R Dorr, Baolin Wu, Rory P Remmel, et al.Clinical Pharmacokinetics|February 6, 2026
A Mycophenolate Pharmacokinetic Study with New Insights into Enterohepatic Recirculation in Kidney Transplant RecipientsMoataz E Mohamed, Abdelrahman Saqr, Guillaume Onyeaghala, et al.Transplantation|February 26, 2019
Genetic Variants Associated With Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome-wide Association StudiesWilliam S Oetting, Baolin Wu, David P Schladt, et al.Clinical Transplantation|December 26, 2022
Higher number of tacrolimus dose adjustments in kidney transplant recipients who are extensive and intermediate CYP3A5 metabolizersKevin A Reininger, Guillaume Onyeaghala, Teresa Anderson-Haag, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 7, 2019
Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: A comparison of four ancestry groupsMoataz E Mohamed, David P Schladt, Weihua Guan, et al.Pageof 5